WICHITA, Kan. – An affiliate of Koch Biological Solutions has acquired a minority equity position in, and entered into collaboration with, Pathway BioLogic (Pathway). Pathway is part of the rapidly growing field of biological plant health solutions, with a specific focus on live microbial products. The company has several products in the market focused on enhancing plant health including PowerBlend, PowerCoat and BioPath among others. Pathway’s products are supported by strong fermentation and formulation capabilities.
With the acquisition of certain assets of Mendel Biotechnology in Dec. 2014, Koch Biological Solutions established a strong discovery platform focused on the identification, development and commercialization of biostimulant products. Combined, the two entities will collaborate to bring new biological solutions to the marketplace.
“Working with Pathway allows us to continue building our product development capabilities and establish a strong commercial presence in the market,” said Bill Boycott, vice president biologicals and origination for Koch.
“Pathway’s success is driven by the quality of our people in rallying around a common vision and mission to continue to innovate and develop biological solutions to increase crop productivity” said Michael Gans, director of operations for Pathway BioLogic.
Additional terms of the deal were not disclosed.